American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 4(58), p. 2415-2417, 2014
DOI: 10.1128/aac.02438-13
Full text: Download
ABSTRACT The discovery of new compounds that are able to inhibit the growth of Burkholderia cenocepacia is of primary importance for cystic fibrosis patients. Here, the mechanism of resistance to a new pyridine derivative already shown to be effective against Mycobacterium tuberculosis and to have good activity toward B. cenocepacia was investigated. Increased expression of a resistance-nodulation-cell division (RND) efflux system was detected in the resistant mutants, thus confirming their important roles in B. cenocepacia antibiotic resistance.